3rd Party Medical Device Industry News

Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

“MERCURIUS Total DRUG-seq represents a new frontier in transcriptome-scale compound [...]

By |2025-06-19T15:15:59+00:00June 19, 2025|3rd Party Medical Device Industry News|Comments Off on Alithea Genomics Launches MERCURIUS™ Total DRUG-seq: A Next-Generation Full-Length Transcriptome Profiling Platform for High-Throughput Compound Screening and Target Validation

Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

Exo Iris® now automatically detects and localizes key pulmonary findings [...]

By |2025-06-18T16:14:26+00:00June 18, 2025|3rd Party Medical Device Industry News|Comments Off on Exo Launches a New Era in Disease Diagnosis with the First FDA-cleared Ultrasound AI for Detection of Pleural Effusion and Consolidation/Atelectasis

Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer

The study finds that CHAI (Computational Histology AI) biomarkers stratify [...]

By |2025-06-13T17:14:05+00:00June 13, 2025|3rd Party Medical Device Industry News|Comments Off on Valar Labs’ CHAI Biomarkers Enhance Bladder Cancer Prediction | New Study in European Urology for Predicting Outcomes of High Grade Ta Bladder Cancer
Go to Top